FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
-12.58%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$202M
AUM Growth
+$202M
(-4.7%)
Cap. Flow
+$23.5M
Cap. Flow
% of AUM
11.59%
Top 10 Holdings %
Top 10 Hldgs %
49.35%
Holding
66
New
5
Increased
32
Reduced
3
Closed
4
Top Buys
| 1 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
$4.86M |
| 2 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
$4.37M |
| 3 |
MDCO
Medicines Co
MDCO
|
$3.19M |
| 4 |
AtriCure
ATRC
|
$2.77M |
| 5 |
Arrowhead Research
ARWR
|
$2.68M |
Top Sells
| 1 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$7.83M |
| 2 |
NXTM
NxStage Medical Inc.
NXTM
|
$3.32M |
| 3 |
Standard BioTools
LAB
|
$2.38M |
| 4 |
Verastem
VSTM
|
$1.72M |
| 5 |
ELGX
Endologix Inc
ELGX
|
$1.52M |
Sector Composition
| 1 | Healthcare | 83.82% |
| 2 | Energy | 3.37% |
| 3 | Real Estate | 2.4% |
| 4 | Financials | 0.28% |
| 5 | Consumer Staples | 0.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AtriCure
ATRC
$1.84B
| $19.7M | 9.73% | 899,362 +126,501 | +16% | +$2.77M |
|
2
NeoGenomics
NEO
$1.13B
| $17M | 8.41% | 2,971,545 +233,602 | +9% | +$1.34M |
|
|
SRGA
3
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $11.3M | 5.6% | 1,996,191 +282,815 | +17% | +$1.61M |
|
|
AKRX
4
DELISTED
Akorn, Inc.
AKRX
| $9.25M | 4.57% | 324,480 +44,382 | +16% | +$1.27M |
|
|
TEAR
5
DELISTED
TearLab Corporation
TEAR
| $7.57M | 3.74% | 3,764,165 +746,293 | +25% | +$1.5M |
|
6
Harvard Bioscience
HBIO
$22M
| $7.49M | 3.7% | 1,982,194 +274,172 | +16% | +$1.04M |
|
|
ENZ
7
DELISTED
Enzo Biochem, Inc.
ENZ
| $7.06M | 3.49% | 2,226,001 +786,671 | +55% | +$2.49M |
|
|
OXFD
8
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $7.03M | 3.47% | 520,755 +72,390 | +16% | +$977K |
|
|
LHCG
9
DELISTED
LHC Group LLC
LHCG
| $6.83M | 3.37% | 152,441 +20,974 | +16% | +$939K |
|
|
TLGT
10
DELISTED
Teligent, Inc
TLGT
| $6.61M | 3.27% | 1,011,217 +130,256 | +15% | +$852K |
|
11
Omnicell
OMCL
$1.5B
| $5.36M | 2.65% | 172,429 +25,508 | +17% | +$793K |
|
12
Insmed
INSM
$28.8B
| $5.06M | 2.5% | 272,393 +40,922 | +18% | +$760K |
|
13
Bio-Techne
TECH
$8.5B
| $5.02M | 2.48% | 54,286 +7,365 | +16% | +$681K |
|
14
Ligand Pharmaceuticals
LGND
$3.15B
| $4.93M | 2.44% | 57,571 +8,456 | +17% | +$724K |
|
|
CYNA
15
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $4.89M | 2.41% | 302,194 +43,588 | +17% | +$705K |
|
|
DOC
16
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $4.86M | 2.4% | +321,979 | New | +$4.86M |
|
17
LeMaitre Vascular
LMAT
$2.16B
| $4.59M | 2.27% | 376,211 +55,443 | +17% | +$676K |
|
|
ARRY
18
DELISTED
Array Biopharma Inc
ARRY
| $4.51M | 2.23% | 988,589 +139,215 | +16% | +$635K |
|
|
ENTL
19
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $4.37M | 2.16% | +242,532 | New | +$4.37M |
|
20
QuidelOrtho
QDEL
$1.95B
| $3.8M | 1.88% | 201,067 +28,399 | +16% | +$536K |
|
|
NXTM
21
DELISTED
NxStage Medical Inc.
NXTM
| $3.79M | 1.87% | 240,229 -210,729 | -47% | -$3.32M |
|
22
Alkermes
ALKS
$4.78B
| $3.76M | 1.86% | 64,148 +9,615 | +18% | +$564K |
|
23
AngioDynamics
ANGO
$417M
| $3.66M | 1.81% | 277,323 +40,631 | +17% | +$536K |
|
|
SPNC
24
DELISTED
Spectranetics Corp
SPNC
| $3.37M | 1.66% | 285,596 +36,409 | +15% | +$429K |
|
|
MDCO
25
DELISTED
Medicines Co
MDCO
| $3.19M | 1.58% | +84,103 | New | +$3.19M |
|